Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Non-cash Items (2016 - 2023)

Iradimed (IRMD) has disclosed Non-cash Items for 10 consecutive years, with $3010.0 as the latest value for Q4 2023.

  • On a quarterly basis, Non-cash Items fell 87.46% to $3010.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $3010.0, a 87.46% decrease, with the full-year FY2023 number at $3010.0, down 87.46% from a year prior.
  • Non-cash Items was $3010.0 for Q4 2023 at Iradimed, down from $24010.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $4.1 million in Q3 2019 to a low of $3010.0 in Q4 2023.
  • A 5-year average of $1.5 million and a median of $1.3 million in 2019 define the central range for Non-cash Items.
  • Peak YoY movement for Non-cash Items: tumbled 99.25% in 2019, then surged 13434.57% in 2020.
  • Iradimed's Non-cash Items stood at $586985.0 in 2019, then plummeted by 60.73% to $230510.0 in 2020, then plummeted by 82.83% to $39576.0 in 2021, then crashed by 39.33% to $24010.0 in 2022, then plummeted by 87.46% to $3010.0 in 2023.
  • Per Business Quant, the three most recent readings for IRMD's Non-cash Items are $3010.0 (Q4 2023), $24010.0 (Q4 2022), and $39576.0 (Q4 2021).